Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-11,320
Closed -$27.6K – 235
2024
Q3
$27.6K Buy
+11,320
New +$25.4K 0.02% 200
2024
Q2
– Sell
-11,645
Closed -$28.9K – 246
2024
Q1
$28.9K Sell
11,645
-2,570
-18% -$6.7K 0.02% 191
2023
Q4
$41.9K Sell
14,215
-1,267
-8% -$3.42K 0.03% 193
2023
Q3
$39.9K Sell
15,482
-2,829
-15% -$8.18K 0.03% 173
2023
Q2
$58.2K Sell
18,311
-1,733
-9% -$5.1K 0.04% 175
2023
Q1
$56.5K Sell
20,044
-732
-4% -$1.92K 0.04% 165
2022
Q4
$57.9K Buy
+20,776
New +$60.5K 0.05% 133

Other funds holding ABEV

New Republic Capital's ABEV Position: Q4 2024 in Review

New Republic Capital sold out of Ambev (ABEV) in Q4 2024, closing a stake of 11,320 shares — an estimated $27.6K sold.

New Republic Capital first reported a position in ABEV in Q4 2022 and held it in 7 quarters. The position peaked at $58.2K in Q2 2023. 399 funds tracked by Wall St. Rank hold ABEV as of Q4 2024.

  • New Republic Capital reported no remaining Ambev position as of Q4 2024 after selling out during the quarter.
  • New Republic Capital sold 11,320 Ambev shares in Q4 2024, an estimated $27.6K.
  • New Republic Capital first reported a position in Ambev in Q4 2022 and held it in 7 quarters.
  • New Republic Capital's Ambev position peaked at $58.2K in Q2 2023.
  • 399 funds tracked by Wall St. Rank held Ambev as of Q4 2024.

Based on New Republic Capital's 13F filing for Q4 2024, filed 29 Jan 2025.